๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-04

Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study) (NCT05782465)

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: National University Hospital, Singapore

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This study is carried out to find out if a customized molecular test can identify a subgroup of patients with very-high-risk of developing stomach cancer within patients with intestinal metaplasia (IM). The investigators hypothesise that the incidence of dysplasia and GC cases in the molecular-test-positive group will be significantly higher than that in the molecular-test-negative group. Such a test has the potential to guide clinicians to better manage patients with IM by allowing endoscopic surveillance to be focused on individuals at very-high-risk of developing stomach cancer, at the same time avoiding or reducing endoscopies for those at lower risk.

Who can join: Review the eligibility criteria below.

Location: Stanford University โ€” Stanford, California

Age range: 50 Years to 75 Years

๐Ÿงช Interventions in This Study

  • Blood Collection, processing and analyses (PROCEDURE)
  • Gastroscopy and biopsies collection (PROCEDURE)
  • Urea Breath Test (DIAGNOSTIC_TEST)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (8 Sites)

  • Stanford University โ€” Stanford, California
  • The Chinese University of Hong Kong โ€” Hong Kong,
  • Nihon University School of Medicine โ€” Tokyo,
  • National University Hospital โ€” Singapore,
  • Singapore General Hospital โ€” Singapore,
  • Tan Tock Seng Hospital, Singapore โ€” Singapore,
  • Yonsei University, Republic of Korea โ€” Seoul,
  • National Taiwan University Hospital โ€” Taipei,

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Stomach Neoplasm clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—